Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing To Power The Next Era Of Dna-Enabled Industries
Amount Raised
$68 Million
Round Type
Series A
EmeryvilleBiotechnologyDescription
Ansa Biotechnologies today announced it has closed an oversubscribed Series A financing round of $68 million led by Northpond Ventures, with participation from new investors RA Capital, Blue Water Life Science Advisors, Altitude Life Science Ventures, Fiscus Ventures, PEAK6 Strategic Capital, Carbon Silicon Ventures, Codon Capital, and existing investors Mubadala Capital, Humboldt Fund, Fifty Years, and Horizons Ventures. The company has raised a total of $82 million from private financings to date.
Quick answer
Ansa Biotechnologies raised $68 Million in a Series A round, dated April 11, 2022. Ansa Biotechnologies is based in Emeryville, California, United States.
- How much did Ansa Biotechnologies raise?
- Ansa Biotechnologies raised $68 Million in a Series A round on April 11, 2022.
- What does Ansa Biotechnologies do?
- Ansa Biotechnologies is redefining DNA synthesis with a bold commitment to quality, customer satisfaction, and success.
- Where is Ansa Biotechnologies based and how big is it?
- Ansa Biotechnologies is based in Emeryville, California, United States. Fundz records about 73 employees.
- Who are the decision-makers at Ansa Biotechnologies?
- Fundz holds 1 contact at Ansa Biotechnologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Ansa Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- SpinaFX raised $6.9M (Series A) on May 26, 2022.
- Mazen Animal Health Inc. raised $11M on May 26, 2022.
- Full Life Technologies raised $37M (Series A) on May 26, 2022.
- Neuvivo raised an undisclosed amount (Funding Round) on May 26, 2022.
- Aurora Cannabis raised $125M (Funding Round) on May 26, 2022.
- CARI Health raised $800K on May 26, 2022.
Who to call at Ansa Biotechnologies, and when
A new round usually means Ansa Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ansa Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ansa Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ansa Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ansa Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAnsa Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.